• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝血酶、蛋白C和蛋白S缺乏的女性发生流产和死产的风险。

The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women.

作者信息

Sanson B J, Friederich P W, Simioni P, Zanardi S, Hilsman M V, Girolami A, ten Cate J W, Prins M H

机构信息

Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Thromb Haemost. 1996 Mar;75(3):387-8.

PMID:8701393
Abstract

Hereditary deficiencies of the naturally occurring anticoagulants are well recognized conditions predisposing to recurrent venous thromboembolism. Since thrombotic phenomena have been implied as a cause of abortion and stillbirth, we hypothesized that these deficiencies increase the risk of fetal demise. A group of 129 female subjects who had been pregnant at least once and who had a family member with documented venous thrombosis associated with a deficiency of AT, PC or PS were studied. We first assessed the obstetric history and subsequently determined the deficiency status. In the 60 deficient subjects 42 (22.3%) of the 188 pregnancies resulted in miscarriage or stillbirth as compared to 23 (11.4%) of the 202 pregnancies in the 69 non-deficient subjects. The relative risk of abortion and stillbirth per pregnancy for deficient women as compared to non-deficient women was 2.0 (95% C.I. 1.2-3.3).

摘要

遗传性天然抗凝物质缺乏是公认的易导致复发性静脉血栓栓塞的疾病。由于血栓形成现象被认为是流产和死产的一个原因,我们推测这些缺乏会增加胎儿死亡的风险。我们研究了一组129名女性受试者,她们至少怀孕过一次,并且有一名家庭成员被记录有与抗凝血酶(AT)、蛋白C(PC)或蛋白S(PS)缺乏相关的静脉血栓形成。我们首先评估她们的产科病史,随后确定其缺乏状态。在60名缺乏抗凝物质的受试者中,188次妊娠中有42次(22.3%)导致流产或死产,而在69名非缺乏抗凝物质的受试者中,202次妊娠中有23次(11.4%)导致流产或死产。与非缺乏抗凝物质的女性相比,缺乏抗凝物质的女性每次妊娠发生流产和死产的相对风险为2.0(95%可信区间1.2 - 3.3)。

相似文献

1
The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women.抗凝血酶、蛋白C和蛋白S缺乏的女性发生流产和死产的风险。
Thromb Haemost. 1996 Mar;75(3):387-8.
2
[Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].121例静脉或动脉血栓形成患者的抗凝血酶III、蛋白C、蛋白S和因子XII遗传性缺乏症
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):21-7.
3
High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.患有蛋白S、蛋白C或抗凝血酶遗传性缺陷的患者,复发性静脉血栓栓塞的长期绝对风险较高。
Thromb Haemost. 2009 Jan;101(1):93-9.
4
Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.在抗凝血酶、蛋白C或蛋白S缺乏的女性中,孕期进行抗凝治疗可降低高胎儿丢失率。
Br J Haematol. 2007 Feb;136(4):656-61. doi: 10.1111/j.1365-2141.2006.06480.x.
5
High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.具有多种血栓形成倾向缺陷的女性发生妊娠相关静脉血栓栓塞的风险较高。
Br J Haematol. 2007 Jul;138(1):110-6. doi: 10.1111/j.1365-2141.2007.06624.x.
6
The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.遗传性抗凝血酶、蛋白C和蛋白S缺乏患者复发性静脉血栓栓塞的风险
Haematologica. 2006 May;91(5):695-8.
7
Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.患有遗传性抗凝血酶III、蛋白C和蛋白S缺乏症的女性服用口服避孕药的血栓形成风险。GTH天然抑制剂研究小组。
Thromb Haemost. 1994 May;71(5):548-52.
8
[Pregnancy and thrombophilia in women with congenital deficit of antithrombin III, protein C, protein S or plasminogen: analysis of 39 cases].
Med Clin (Barc). 1993 Feb 13;100(6):201-4.
9
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.抗凝血酶III、蛋白C和蛋白S的遗传性缺乏:有静脉血栓形成病史患者中的患病率及合理的患者筛查标准。
Blood Coagul Fibrinolysis. 1992 Oct;3(5):547-53.
10
Incidence of venous thromboembolism in families with inherited thrombophilia.遗传性易栓症家族中静脉血栓栓塞的发病率。
Thromb Haemost. 1999 Feb;81(2):198-202.

引用本文的文献

1
Effect of prednisolone on live birth rate in women with unexplained recurrent pregnancy loss: a study protocol for a double-blind, placebo-controlled, multicentre, randomised controlled trial (PREMI-study).泼尼松龙对不明原因复发性流产女性活产率的影响:一项双盲、安慰剂对照、多中心随机对照试验的研究方案(PREMI研究)
BMJ Open. 2025 Jun 19;15(6):e096545. doi: 10.1136/bmjopen-2024-096545.
2
Validation for the function of protein C in mouse models.验证蛋白 C 在小鼠模型中的功能。
PeerJ. 2024 Apr 24;12:e17261. doi: 10.7717/peerj.17261. eCollection 2024.
3
Coagulation Status in Women with a History of Missed Abortion.
有过稽留流产史的女性的凝血状态。
Reprod Sci. 2024 Feb;31(2):480-487. doi: 10.1007/s43032-023-01355-0. Epub 2023 Sep 22.
4
Overcoming heparin resistance in pregnant women with antithrombin deficiency: a case report and review of the literature.抗凝血酶缺乏的孕妇中肝素抵抗的克服:一例报告及文献综述
J Med Case Rep. 2018 Jun 16;12(1):169. doi: 10.1186/s13256-018-1711-2.
5
Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia.诊断为遗传性血栓形成倾向的复发性流产患者的产科结局
Ir J Med Sci. 2017 Aug;186(3):707-713. doi: 10.1007/s11845-017-1569-0. Epub 2017 Feb 7.
6
Inherited thrombophilia: a double-edged sword.遗传性血栓形成倾向:一把双刃剑。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):1-9. doi: 10.1182/asheducation-2016.1.1.
7
The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages.复发性流产女性中血栓形成倾向的患病率及预防流产的抗凝治疗效果
Clin Appl Thromb Hemost. 2018 Jan;24(1):122-128. doi: 10.1177/1076029616675967. Epub 2016 Oct 30.
8
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.阿司匹林和/或肝素用于患有或不患有遗传性血栓形成倾向的不明原因复发性流产女性。
Cochrane Database Syst Rev. 2014 Jul 4;2014(7):CD004734. doi: 10.1002/14651858.CD004734.pub4.
9
Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice?易栓症与复发性流产:肝素仍是首选药物吗?
Sultan Qaboos Univ Med J. 2014 Feb;14(1):e26-36. doi: 10.12816/0003333. Epub 2014 Jan 27.
10
Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.FXIII Val34Leu 与早孕期流产风险:纤维蛋白原浓度的影响。
J Clin Lab Anal. 2013 Nov;27(6):444-9. doi: 10.1002/jcla.21626.